PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1429.41%
Net income growth above 1.5x MCHP's 0.26%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-2.92%
Negative yoy D&A while MCHP is 1.87%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
100.00%
Well above MCHP's 50.26% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-6.00%
Both cut yoy SBC, with MCHP at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
80.61%
Less working capital growth vs. MCHP's 280.70%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
46.79%
AR growth while MCHP is negative at -100.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-86.74%
Negative yoy inventory while MCHP is 7.29%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
100.00%
A yoy AP increase while MCHP is negative at -100.00%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
250.00%
Growth well above MCHP's 249.17%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-23.08%
Both negative yoy, with MCHP at -237.35%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
121.91%
Operating cash flow growth above 1.5x MCHP's 17.30%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-11.63%
Both yoy lines negative, with MCHP at -112.76%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
50.96%
Some acquisitions while MCHP is negative at -67.89%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-55.86%
Both yoy lines negative, with MCHP at -9656.91%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-19.81%
Both yoy lines are negative, with MCHP at -89.16%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
-60.88%
Both yoy lines negative, with MCHP at -364.88%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
5.56%
We slightly raise equity while MCHP is negative at -23.42%. John Neff sees competitor possibly preserving share count or buying back shares.
-147.52%
Both yoy lines negative, with MCHP at -324.30%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.